FIELD: medicine, oncology.
SUBSTANCE: one should study the activity of catalase in the tissue of malignant mammary tumor and its perifocal area, and at ratio coefficient of catalase activity in the tissue of malignant mammary tumor to that in the tissue of perifocal area being equal to 1.0 ± 0.2 one should predict the chance for the development of new foci of lesion before their clinical manifestation, that provides necessary treatment in due time.
EFFECT: higher efficiency of prediction.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING METACHRONOUS COLON CANCER | 2010 |
|
RU2447447C1 |
| METHOD OF PREDICTING DEVELOPMENT OF METACHRONOUS HYPERPLASTIC PROCESSES IN ORGANS OF FEMALE REPRODUCTIVE SYSTEM | 2010 |
|
RU2436517C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
| METHOD FOR PREDICTING RELAPSE DEVELOPMENT AT UTERINE BODY CANCER | 2002 |
|
RU2250077C2 |
| METHOD FOR DETERMINATION OF MALIGNANT PROCESS ABUNDANCE | 2005 |
|
RU2289815C1 |
| METHOD FOR PREDICTION OF DURATION OF RECURRENCE-FREE INTERVAL IN PATIENTS WITH RECTAL CANCER | 2009 |
|
RU2415429C1 |
| METHOD FOR PROGNOSTICATION OF DEVELOPMENT OF METACHRONNIC CARCINOMA OF SKIN | 2002 |
|
RU2241232C2 |
| MEANS FOR BREAST CANCER PREDICTION | 2016 |
|
RU2631940C1 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
